INTRODUCTION
============

Spinal cord injury (SCI) is a leading cause of permanent disability, resulting in partial or complete loss of motor and sensory function below the lesion site ([@B23]). Inflammatory and immune responses are one of the major factors exacerbating the pathogenesis after SCI. It is known that blood-brain barrier (BBB) permeability and thereby blood infiltration is increased after SCI. Infiltrated cells such as macrophage and neurophil are also known to be involved in inflammation after SCI. Furthermore, proteinases and in particular, matrix metalloproteinases (MMPs), are likely mediators of early secondary vascular pathogenesis after SCI ([@B18]; [@B2]).

MMPs are soluble and cell-surface bound zincdependent endopeptidases ([@B4]) that degrade the extracellular matrix and other extracellular proteins ([@B21]). MMPs also play important roles in remodeling of the extracellular matrix, tissue morphogenesis, and wound healing ([@B24]). However, excessive proteolytic activity of MMPs can be detrimental, leading to numerous pathologic conditions, including BBB disruption ([@B19]) and inflammation ([@B17]). For example, MMPs are significantly upregulated after SCI in mice, rat and human ([@B18]; [@B23]; [@B5]). Furthermore, MMPs mainly expressed during the first weeks after injury are known to be involved in the destructive inflammation events of protein breakdown and phagocytosis by infiltrating neutrophils and macrophages and in enhanced permeability of the blood spinal cord barrier ([@B18]; [@B23]; [@B5]). In particular, the activities of MMP-2 and MMP-9, which degrade types IV and V collagen, and thus modify constituents of basal laminae ([@B24]) are known to be increased within 1 d after SCI ([@B18]; [@B6]). Moreover, it was clearly demonstrated that the pharmacological blockade of MMPs, limited to the first 3 d after injury, is neuroprotective and promotes long-term recovery of hindlimb function ([@B18]). However, this beneficial response is lost when treatment is extended beyond the acutely injured cord to include wound healing and tissue remodeling ([@B22]; [@B8]). These data suggest that the attenuation of MMP activities in early stage after SCI may exert beneficial effect and improve functional recovery.

The roots of *Bupleurum falcatum* have been used in Oriental countries as a herbal medicine for treating hepatitis, nephritis, influenza, inflammation, and bacterial and viral infections ([@B12]). The extract of *Bupleurum falcatum* (BF) contains various compounds including a series of triterpene saponins namely saikosaponins ([@B7]). Previous reports showed that saikosaponins exhibit a variety of pharmacological activites including anti-inflammatory, immunomodulatory and anti-bacterial activites *in vitro* and *in vivo* ([@B25]; [@B12]). Furthermore, saikosaponins have been shown to modulate the gene expression or activation of MMP-2 in endothelial cells and spleen cells from picryl chloride-induced ear contact sensitivity mice ([@B20]; [@B29]). These observations suggest that BF may exert anti-inflammatory effect by inhibiting MMPs activity.

In this study, we showed that the systemic administration of BF significantly improves functional recovery after SCI in part by inhibiting the expression and/or activation of MMP-2, MMP-9 and inflammatory mediators, thereby inhibiting apoptotic cell death and reducing lesion volume.

MATERIALS AND METHODS
=====================

Spinal cord injury
------------------

Adult male Sprague Dawley \[Sam:TacN (SD) BR; Samtako, Osan, Korea\] rats were subjected to moderate contusion injury (10 g×25 mm) as described previously ([@B28]). For the sham-operated controls, the animals underwent a T10 laminectomy without weight-drop injury. Surgical interventions and postoperative animal care were performed in accordance with the Guidelines and Policies for Rodent Survival Surgery provided by the Animal Care Committee of the Kyung Hee University.

Preparation of BF
-----------------

The dried roots of *Bupleurum falcatum* were extracted with 70% ethanol as described previously ([@B11]). The ethanol filtrate was evaporated in vacuo, and powdered BF was stored at -20℃ until use. By HPLC analysis, BF contains saikosaponin A, B1, B2, B3, B4, C, D, G, H and I.

BF administration
-----------------

Powdered BF were suspended in sterile deionized water and administrated orally at a dose of (100 mg/kg) beginning at 2 h after SCI and then once a day for 14 d.

RNA isolation and RT-PCR
------------------------

RNA isolation using TRIZOL Reagent (Invitrogen, Carlsbad, CA) and cDNA synthesis were performed as described previously ([@B13]). The primers used for MMP-2, MMP-9, iNOS, COX-2, TNF-α, IL-1β and GAPDH were synthesized by the Genotech Corp (Daejeon, Korea). Details of primers used for PCR in this study are shown in [Table 1](#T1){ref-type="table"}. GAPDH was used as an internal control. Experiments were repeated three times and the values obtained for the relative intensity were subjected to statistical analysis. The gels shown in figures are representatives of results from three separate experiments.

Gelatin zymography
------------------

Total protein extracts from spinal cord samples at 1 d after injury were prepared as described previously ([@B28]). Spinal cord tissues (1 cm) were homogenized in a lysis buffer and the tissue homogenates were incubated for 20 min at 4℃, and centrifuged at 25,000×g for 30 min at 4℃. The protein level of the supernatant was determined using the BCA assay (Pierce, Rockford, IL). Gelatin zymography was performed by using 10% zymogram gel (Invitrogen) as previously described ([@B6]). In brief, 50µg proteins were mixed with sample buffer and loaded without boiling. After electrophoresis, the gel were soaked in 2.5% Triton X-100, rinsed, and incubated for 24 h at 37℃ in developing buffer (50 mM Tris-HCl, pH 8.5, 0.2 M NaCl, 5 mM CaCl~2~, 0.02% Brii35). After incubation, gels were stained with 0.5% Coomassie blue and then destained. Clear bands on the zymogram were indicative of gelatinase activity.

Behavioral tests
----------------

Examination of functional deficits after injury was conducted by using the 21-point Basso-Beattie-Bresnahan (BBB) locomotion scale, inclined plane test and foot print analysis as previously described ([@B28]).

Tissue preparation
------------------

After SCI, spinal cord sections were prepared as described previously ([@B28]). In brief, animals were perfused via cardiac puncture with 4% paraformaldehyde. A 20-mm section of the spinal cord, centered at the lesion site, was dissected out, post-fixed and placed in 30% sucrose. The segment was embedded in OCT for frozen sections, and longitudinal or transverse sections were then cut at 10 or 20µm on a cryostat (CM1850; Leica, Germany).

Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL)
---------------------------------------------------------------------------------------------------------

One day after injury, serial spinal cord sections (20µm thickness) were collected and every 100 µm section was processed for TUNEL as previously described ([@B28]). Only those cells showing morphological features of nuclear condensation and/or compartmentalization only in the gray matter (GM) were counted as a TUNEL-positive. Quantitation of TUNEL-positive cells was accomplished by counting the number of cells labeled positively as described previously ([@B26]).

Assessment of lesion volume
---------------------------

Lesion volume, using rats employed for behavioral analyses, was assessed as described previously ([@B27]). In brief, serial longitudinal sections (10µm) through the dorsoventral axis of the spinal cord were used to determine lesion volume. Every 50µm, sections were stained with Cresyl violet acetate and studied with light microscopy. Areas at each longitudinal level were determined, and the total lesion volume derived by means of numerical integration of sequential areas.

Statistical analysis
--------------------

Data presented as the mean±SD values. Comparisons between vehicle and BF treated groups were made by unpaired Student\'s t test. Behavioral scores from BBB analysis and inclined plane tests were analyzed by repeated measures ANOVA (time vs treatment). Tukey\'s multiple comparison was used as Post hoc analysis. Statistical significance was accepted with p\<0.05. All statistical analyses were performed by using SPSS 15.0 (SPSS Science, Chicago, IL).

RESULTS
=======

BF inhibits MMP-2 and MMP-9 expression and activation after SCI
---------------------------------------------------------------

It has been known that saikosaponins modulates the gene expression or activation of MMP-2 in endothelial cells and spleen cells from picryl chloride-induced ear contact sensitivity mice ([@B20]; [@B29]). To test the hypothesis whether BF may inhibit MMP-2 and MMP-9 activation after SCI, we first examined the effect of BF on the expression of MMP-2 and MMP-9 by RT-PCR at 1 d after injury. A basal level of MMP-2 expression was detected in sham control. A significant upregulation of MMP-2 expression was observed at 1 d after SCI and BF treatment significantly reduced the MMP-2 mRNA expression ([Fig. 1A](#F1){ref-type="fig"}, [B](#F1){ref-type="fig"}). Similarly, MMP-9 mRNA was markedly increased at 1 d after SCI and BF treatment also significantly attenuated the MMP-9 mRNA expression ([Fig. 1A](#F1){ref-type="fig"}, [B](#F1){ref-type="fig"}). However, MMP-9 expression was not observed in the sham control. Next, we examined the enzyme activities of MMP-2 and MMP-9 by gelatin zymography using spinal cord total extract from 1 d after injury. As shown in [Figure 1C](#F1){ref-type="fig"}, active form of MMP-2 and MMP-9 was strongly induced at 1 d after injury. Pro-MMP-2 and pro-MMP-9 were also induced by SCI. Furthermore, BF treatment significantly reduced the degree of activation of MMP-2 and MMP-9 when compared to vehicle-treated control (e.g., active MMP-2; BF 1.66±0.08 vs vehicle 3.22±0.22, p\<0.05/active MMP-9; BF 5.3±0.11 vs vehicle 7.5±0.25, p\<0.05) ([Fig. 1B](#F1){ref-type="fig"}, [D](#F1){ref-type="fig"}).

BF inhibits the expression of inflammatory mediators after SCI
--------------------------------------------------------------

It has been known that BBB disruption by MMPs including MMP-2 and MMP-9 induces blood infiltration and thereby contributes to inflammation after SCI. Since BF reduced the expression and activity of MMP-2 and MMP-9 after SCI ([Fig. 1](#F1){ref-type="fig"}), we hypothesized that BF would inhibit the expression of inflammatory factors after SCI. As shown in [Fig. 2A](#F2){ref-type="fig"}, TNF-α, IL-1β, COX-2 and iNOS mRNA expression were markedly increased after SCI as reported ([@B14]; [@B26]). In particular, BF treatment significantly alleviated the expression levels of pro-inflammatory cytokines and mediators when compared with those of vehicletreated control at 1 d after injury ([Fig. 2](#F2){ref-type="fig"}).

BF inhibits apoptotic cell death after SCI
------------------------------------------

Trauma to the spinal cord results in extensive apoptotic cell death ([@B16]; [@B15]). Based on the anti-inflammatory effects of BF in the injured spinal cord ([Fig. 2](#F2){ref-type="fig"}), we hypothesized that BF would inhibit apoptotic cell death after SCI. Many TUNEL-positive cells were seen mostly within the lesion area in the gray matter (GM) at 1 d after injury. As shown in [Fig. 3](#F3){ref-type="fig"}, BF treatment significantly decreased the number of TUNEL-positive cells when compared to the vehicle-treated control (BF 132±9 vs. Vehicle 205±17 cells, p\<0.05) ([Fig. 3B](#F3){ref-type="fig"}). Thus, our results indicate that BF inhibits apoptotic cell death after injury.

BF improves functional recovery after SCI
-----------------------------------------

Previous report showed that pharmacological inhibition of MMPs at a early stage after SCI improves locomotor recovery ([@B18]). Since BF treatment inhibited the expression and activity of MMP-2 and MMP-9 and also attenuated apoptotic cell death after injury ([Fig. 1](#F1){ref-type="fig"} and [3](#F3){ref-type="fig"}), we expected that BF would improve functional recovery following injury. Injured rats were treated with BF (100 mg/kg) for 14 consecutive days and functional recovery was then evaluated for 35 d using the BBB rating scale, inclined plane test and footprint analysis. The hindlimbs paralyzed immediately after injury were spontaneously recovered within 7 to 14 d after injury ([Fig. 4A](#F4){ref-type="fig"}) as in previous report ([@B28]). The BBB scores were significantly higher in rats treated with 100 mg/kg of BF by 14 to 35 d after SCI than in vehicle-treated rats (35 d, BF 11.25±0.5 vs Vehicle 9.0±1.0, p\<0.05) ([Fig. 4A](#F4){ref-type="fig"}). The angle of incline, determined 1\~4 weeks after injury, was also significantly higher in BFtreated rats than in vehicle-treated rats at 4 weeks after SCI (4 weeks, BF 60±2.1 vs Vehicle 53±2.2, p\<0.05) ([Fig. 4B](#F4){ref-type="fig"}). Finally, footprint analyses obtained from sham-treated, vehicle-treated and BFtreated rats at 35 d after SCI revealed that BFtreated rats show more consistent forelimb-hindlimb coordination and less toe drag than in vehicle control ([Fig. 4C](#F4){ref-type="fig"}). With the 25 mm insult used in the present study, the hind paws as well as the central pads of vehicle-treated animals were not clearly recorded because of the hindlimb drags ([Fig. 4C](#F4){ref-type="fig"}). Thus, we didn\'t quantify footprint analysis using toe spread and ipsilateral distances (limb coordination) in this study.

BF reduces lesion volume after SCI
----------------------------------

The functional deficit after SCI is known to be correlated with the massive tissue loss ([@B3]). To examine whether BF preserves spinal cord tissue after injury, we measured the lesion volume using rats tested for behavioral analysis. As shown in [Fig. 4D](#F4){ref-type="fig"}, BF treatment significantly reduced the lesion volume at 38 d after injury than in vehicle-treated rats (BF 4.2±1.2 mm^3^ vs Vehicle 8.5±0.7 mm^3^, p\<0.05).

DISCUSSION
==========

In this study, we demonstrated the first time that after moderate contusion injury to the rat spinal cord, BF treatment improved functional recovery by inhibiting the expression and/or activation MMP-2, MMP-9 and inflammatory mediators, thereby attenuating apoptotic cell death.

A critical finding in this study is that BF can effectively inhibit MMP upregulation, thereby improve locomotor function after SCI. The functional impairment after SCI may be attributed to the early involvement of MMPs in secondary pathogenesis after injury. It has been known that in brain and injured spinal cord, MMPs including MMP-2 and MMP-9, contribute to early secondary pathogenesis by disrupting the BBB and promoting inflammation ([@B19]; [@B18]), oxidative stress ([@B8]) and demyelination ([@B1]). It was also known that animals treated with an MMP inhibitor within the first 3 d after injury showed less disruption of the BBB, attenuation of neutrophil infiltration, and significant locomotor recovery compared with vehicletreated control ([@B18]). Our data indicate that BF treatment significantly inhibited the expression and activity of MMP-2 and MMP-9 after SCI ([Fig. 1](#F1){ref-type="fig"}). Also, the expression of inflammatory mediators such as TNF-α, IL-1β, COX-2 and iNOS was significantly decreased following BF treatment ([Fig. 2](#F2){ref-type="fig"}). In addition, the number of TUNELpositive cells in the GM at 1 d and the lesion volume at 35 d after injury was significantly inhibited by BF treatment ([Fig. 3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}). Thus, these results suggest that the effect of neuroprotection followed functional recovery by BF are likely mediated in part by inhibiting MMP-2 and MMP-9, then attenuating the increase of BBB permeability and blood infiltration after SCI. However, we did not examine whether BF inhibits BBB disruption and blood infiltration after injury in this study. Further study may be required to elucidate the effects of BF on BBB permeability and blood infiltration after SCI.

It has also been known that the beneficial effect of MMP inhibition is lost by long term blockade of MMPs for the first week after SCI ([@B22]). Hsu et al. ([@B9]) also demonstrated that MMP-2 increased between 7 and 14 d after injury, was involved in wound healing and tissue remodeling after SCI. In this study, we observed the inhibition of MMP-2 by BF at 1 d after injury. In addition, it was reported that the general MMPs blocker, GM6001 treatment for first 3 d after SCI improved functional recovery ([@B18]). Furthermore, when we examine the effect of BF on MMP-2 at 7 and 14 d after injury, neither gene expression nor gelatinase activity of MMP-2 was changed (data not shown). Therefore we believe that the inhibition of MMP-2 and MMP-9 activity by BF at 1 d after injury may contribute to beneficial to functional recovery. MMP-12 is also known to be upregulated at 5 d and involved in the dysfunction in BBB permeability and inflammation after SCI ([@B23]). Furthermore, Wells et al. ([@B23]) showed that functional recovery was significantly improved in MMP-12 null mice compared with wild-type controls. Therefore, further study may be needed to examine the effect of BF on MMP-12 after SCI.

We examined the neuroprotective effect of BF after SCI using total ethanol extract in the present study. During the experiment, neither significant side effects nor an increase in mortality by BF treatment were observed (data not shown). As a previous report showed that aikosaponins, the major components in the roots of *Bupleurum falcatum*, exhibit anti-inflammatory, immunomodulatory activites *in vitro* and *in vivo* ([@B25]; [@B10]), further study to find active components exhibiting MMP inhibition and examine their neuroprotection after SCI will be processed.

In summary, our results indicate that the inhibition of MMP-2 and MMP-9 by BF may account for in part its neuroprotective effect and provide an evidence for BF as a potential therapeutic agent after SCI.
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![BF inhibits the expression and activation of MMP-2 and -9 after SCI. Total RNA and protein extracts from spinal cord samples at 1 d after injury were prepared as described in the Methods section. (A) RT-PCR of MMP-2 and MMP-9 and (B) quantitative analysis (intensity relative to sham value) of RT-PCR (n=3/group). ^\*^p\<0.05. (C) Gelatine zymography of MMP-2 and MMP-9. (D) Quantitative analysis (intensity relative to sham value) of zymography (n=3/group). Data are presented as means±SD from three separate experiments. ^\*^p\<0.05.](en-19-146-g001){#F1}

![BF inhibits the expression of inflammatory factors after SCI. (A) Total RNA isolation from spinal cord samples at 1 d after injury were processed as described in the Method section (n=3/group). (A) RT-PCR for TNF-α, IL-1β, COX-2 and iNOS at 1 d after SCI. (B) Quantitative analysis shows that the expression of proinflammatory factors was significantly reduced by BF treatment. Data represent mean±SD from three separate experiments. ^\*^p\<0.05.](en-19-146-g002){#F2}

![The effect of BF on apoptotic cell death after SCI. Spinal cord tissues from 1 d after injury were processed for TUNEL staining as described in the Method section (n=5/group). (A) TUNEL-positive cells in the GM at 1 d after injury. Representative images were from the sections selected 1 mm rostral to the lesion epicenter. Bar, 50µm. (B) Quantitative analysis of TUNEL-positive cells in the GM at 1 d after injury. Serial transverse sections (10µm thickness) were collected every 100 µm from 2 mm rostral to 2 mm caudal to the lesion epicenter (total 40 sections for neurons). Data represent mean±SD obtained from five separate experiments. ^\*^p\<0.05.](en-19-146-g003){#F3}

![BF improves functional recovery and reduces lesion volume after SCI. After SCI, BF was administered orally at a dose of 100 mg/kg beginning at 2 h after SCI and then once a day for 14 d. Functional recovery was assessed by BBB, inclined plane test and footprint analysis (n=10/group). (A) BBB scores. (B) Inclined plane test. Note that BF treatment significantly increased BBB score and angle of incline after SCI. Data represent mean±SD. ^\*^p\<0.05. (C) Representative footprints obtained from each group at 35 d after SCI. (D) Quantitative analysis of lesion volumes at 38 d after injury (n=5/group). Data are presented as means±SD from five separate experiments. ^\*^p\<0.05.](en-19-146-g004){#F4}
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